A 5-year-old male with Gaucher's disease type 3 developed progressive mesenteric and mediastinal lymphadenopathy over 12 months, despite enzyme replacement therapy, contributing to the development of a protein-losing enteropathy. These complications are unique, indicating poorly accessible, differentially responsive compartments in patients with Gaucher's disease who are receiving enzyme therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jpeds.2006.10.062 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!